Indogulf Cropsciences Q1 FY27 earnings call

Indogulf Cropsciences reported a challenging Q1 FY27 with revenue from operations declining 11% YoY to Rs. 168.5 crores, compared to Rs. 189.4 crores in Q1 FY26. However, revenue increased by approximately 12% QoQ from Rs. 150.8 crores in Q4 FY26. Gross margins significantly improved to 28% from 22% in Q1 FY26, and EBITDA margin expanded to 5.7% from 5.2%, despite a 4% absolute decline in EBITDA to Rs. 9.6 crores. PAT stood at Rs. 2.4 crores, down from Rs. 3.9 crores in Q1 FY26.

The quarter was significantly impacted by delayed and uneven southwest monsoons, affecting Kharif sowing, crop protection applications, and dealer inventory decisions. This led to a portion of Q1 demand being deferred into subsequent periods. Farmers exhibited cautious purchasing behavior due to uncertainty around crop conditions and lower realization for some commodities, contributing to the revenue decline.

Despite top-line challenges, the company demonstrated resilience through improved operational efficiency. Capacity utilization increased to 70% in Q1 FY27 from 52% in FY26. The product mix saw crop protection contributing 87%, while biologicals and plant nutrients each contributed 3%. Notably, the share of biologicals and plant nutrients in brand sales increased from 11% last quarter to 22%, indicating a shift towards higher-margin products.

Indogulf made significant strides in international expansion. In Taiwan, the company completed registration for Mancozeb 80% WP and has another formulation registration in progress. Import permission for the Indo-Apache brand was received in Sri Lanka, and five technical registrations are now in place in Saudi Arabia. The company is also evaluating market opportunities in Venezuela, Brazil, and across Africa, including Kenya, Nigeria and Tanzania, aiming for global diversification.

The company's strategy focuses on expanding its biological and sustainable product portfolio, increasing contributions from specialty and higher-value products, and deepening farmer engagement. Management aims to evolve into an integrated agri-solution platform, combining crop protection, plant nutrients, and biologicals. While acknowledging the challenges posed by El Nino and the current industry environment, the company remains focused on strengthening its underlying business for sustainable long-term growth.

Capital work-in-progress stood at Rs. 76.4 crores in FY26, up from Rs. 57.1 crores in FY25, reflecting ongoing investments in manufacturing infrastructure, including expansion at Barwasni and development of the DF manufacturing facility. Finance costs rose by 19% YoY due to planned growth and inventory build-up. Management expects to reduce finance costs in the near term through inventory liquidation and improved collections.

To improve return ratios like ROCE and ROE, management is focusing on enhancing the product mix by prioritizing high-margin projects such as biologicals and plant nutrients. Other key levers include improving manufacturing yield, energy efficiency, procurement, and supply chain optimizations. Expanding the product portfolio and entering new markets are also expected to contribute to better margins and asset utilization, driving overall profitability.